Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Obstet Gynecol. Nov 10, 2013; 2(4): 137-142
Published online Nov 10, 2013. doi: 10.5317/wjog.v2.i4.137
Table 1 Time-points of optimal cytoreduction and survival result of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of 1021 patients with carcinomatosis from ovarian cancer
Ref.Patients (n)Time-point of optimal cytoreductionMedian disease free survival (mo)Overall 3-yr survival (%)Overall 5-yr survival (%)
Ansaloni et al[21]391, 2, 3, 4, 5421NRNR
Deraco et al[28]564, 5NRNR23
Pomel et al[30]312, 327672NR
Bereder et al[31]2462, 4, 5136035
Pavlov et al[32]561, 4, 526NRNR
Fagotti et al[33]254, 510NRNR
Guardiola et al[34]47214632NR
Di Giorgio et al[35]471, 4, 520NR17
Bae et al[36]672, 3NRNR66
Cotte et al[37]81519NRNR
Helm et al[38]18510NRNR
Rufián et al[39]331, 4NR4637
Raspagliesi et al[40]403, 511NR15
Reichman et al[41]131, 41555NR
Gori et al[42]293571NRNR
Look et al[43]281, 517NRNR
Ryu et al[44]572, 326NR54
Piso et al[45]191, 4, 518NR15
Zanon et al[46]302173512
Chatzigeorgiou et al[47]20521NRNR
de Bree et al[48]194, 5266342
Cavaliere et al[49]20NRNR502NR